139 related articles for article (PubMed ID: 21891993)
1. [Infliximab-induced lupus erythematosus in a case of ulcerative colitis].
Nishikawa J; Miyazaki T; Suzuki N; Itaya Y; Yamawaki H; Mihara H; Hasumoto Y; Fujinami H; Ogawa K; Hosokawa A; Kudo T; Sugiyama T
Nihon Shokakibyo Gakkai Zasshi; 2011 Sep; 108(9):1535-9. PubMed ID: 21891993
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab.
Fok KC; Ng WW; Henderson CJ; Connor SJ
J Crohns Colitis; 2012 Jul; 6(6):708-12. PubMed ID: 22398084
[TBL] [Abstract][Full Text] [Related]
3. Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis.
Marques M; Magro F; Cardoso H; Carneiro F; Portugal R; Lopes J; Costa Santos C
Inflamm Bowel Dis; 2008 May; 14(5):723-5. PubMed ID: 17929297
[No Abstract] [Full Text] [Related]
4. Vitiligo in a patient receiving infliximab for refractory ulcerative colitis.
Ismail WA; Al-Enzy SA; Alsurayei SA; Ismail AE
Arab J Gastroenterol; 2011 Jun; 12(2):109-11. PubMed ID: 21684486
[TBL] [Abstract][Full Text] [Related]
5. Suicide attempt in ulcerative colitis patient after 4 months of infliximab therapy--a case report.
Eshuis EJ; Magnin KM; Stokkers PC; Bemelman WA; Bartelsman J
J Crohns Colitis; 2010 Nov; 4(5):591-3. PubMed ID: 21122565
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic meningitis with infliximab for ulcerative colitis.
Tissot B; Visée S; Pilette C; Prophette B; Puechal X
Gastroenterol Clin Biol; 2006 Dec; 30(12):1420-2. PubMed ID: 17211348
[No Abstract] [Full Text] [Related]
7. Infliximab-induced reactivated Langerhan's cell histiocytosis in a patient with ulcerative colitis.
Rodríguez HN; García I; Alba A; Igea F
Inflamm Bowel Dis; 2009 Sep; 15(9):1286-7. PubMed ID: 18942740
[No Abstract] [Full Text] [Related]
8. Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab.
Havel J; Aboutalebi S; Doughty L; Wirges M
J Drugs Dermatol; 2008 Aug; 7(8):796-8. PubMed ID: 18720701
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced lupus erythematosus presenting with cardiac tamponade: a case report and literature review.
Harnett DT; Chandra-Sekhar HB; Hamilton SF
Can J Cardiol; 2014 Feb; 30(2):247.e11-2. PubMed ID: 24373757
[TBL] [Abstract][Full Text] [Related]
10. Vogt-Koyanagi-Harada Disease and Systemic Lupus Erythematosus Occurring during Adalimumab Therapy for Ulcerative Colitis.
AlBloushi AF; Al-Hadlaq OS; AlRashed FA; Abu El-Asrar AM
Middle East Afr J Ophthalmol; 2020; 27(3):185-187. PubMed ID: 33488017
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease.
Zella GC; Weinblatt ME; Winter HS
J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):355-8. PubMed ID: 19516196
[No Abstract] [Full Text] [Related]
12. Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy.
Rojas-Feria M; Eslam M; Castro-Fernández M; Guerrero P; Larraona-Moreno JL; Romero-Gómez M
J Crohns Colitis; 2011 Dec; 5(6):608-11. PubMed ID: 22115382
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis jiroveci (carinii) pneumonia following a second infusion of infliximab in a patient with ulcerative colitis.
Estrada S; García-Campos F; Calderón R; Delgado E; Bengoa R; Enciso C
Inflamm Bowel Dis; 2009 Feb; 15(2):315-6. PubMed ID: 19058233
[No Abstract] [Full Text] [Related]
14. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
[No Abstract] [Full Text] [Related]
15. A case report: ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis.
Kinnunen U; Färkkilä M; Mäkisalo H
J Crohns Colitis; 2012 Jul; 6(6):724-7. PubMed ID: 22398069
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease and lupus: a systematic review of the literature.
Katsanos KH; Voulgari PV; Tsianos EV
J Crohns Colitis; 2012 Aug; 6(7):735-42. PubMed ID: 22504032
[TBL] [Abstract][Full Text] [Related]
17. Infliximab Efficacy and Safety in an Ulcerative Colitis Patient with Systemic Lupus Erythematosus.
Ben-Horin S; Ungar B; Eliakim R; Langevitz P
J Crohns Colitis; 2016 Jun; 10(6):752-3. PubMed ID: 26826571
[No Abstract] [Full Text] [Related]
18. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.
Lawson MM; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
20. Infliximab anaphylaxis in siblings.
Teich N
Inflamm Bowel Dis; 2011 Aug; 17(8):E108. PubMed ID: 21567666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
